COVID-19 and kidneys

por M. S. Shamkhalova, N. G. Mokrysheva, M. V. Shestakova
Publicado 2020

High level of glycated hemoglobin (HbA_1c) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus

por M. V. Shestakova, I. V. Kononenko, Z. A. Kalmykova, A. V. Zheleznyakova, N. G. Mokrysheva
Publicado 2021

Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19

por Z. A. Kalmykova, I. V. Kononenko, I. A. Sklyanik, M. V. Shestakova, N. G. Mokrysheva
Publicado 2020

Endocrinology research centre statement about COVID-19 vaccination of diabetes mellitus patients

por I. I. Dedov, M. V. Shestakova, A. Yu. Mayorov, T. V. Nikonova, G. R. Galstyan, M. Sh. Shamkhalova, O. K. Vikulova, V. Yu. Kalashnikov, N. G. Mokrysheva
Publicado 2021